EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome—Causes, Clinical Presentation, and Therapeutic Options

Bilal Bashir, Jan H Ho, Paul Downie, Paul Hamilton, Gordon Ferns, Dev Datta, Jaimini Cegla, Anthony S Wierzbicki iD, Charlotte Dawson, Fiona Jenkinson, Hannah Delaney, Michael Mansfield iD und 5 weitere

Metabolites · 30.04.2023 · 13 (5) · 621

DOI: 10.3390/metabo13050621 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 30.04.2023. Verfasst von Bilal Bashir und 16 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biology Medicine and Health, University of Manchester, Manchester M13 9PL, UK. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have reviewed the genetic basis of chylomicronaemia, the difference between monogenic and polygenic hypertriglyceridaemia, its effects on pancreatic, cardiovascular, and microvascular complications, and current and potential future pharmacotherapies. Severe hypertriglyceridaemia (TG > 10 mmol/L or 1000 mg/dL) is rare with a prevalence of

Schlagwörter

Stichwörter der Autor:innen

atherosclerosischylomicronaemia syndromehypertriglyceridaemiamicrovascular complicationspancreatitisvolanesorsen

Autor:innen und Institutionen

  • Faculty of Biology Medicine and Health, University of Manchester, Manchester M13 9PL, UK.
  • Department of Endocrinology, Diabetes & Metabolism, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
  • Department of Endocrinology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK.
  • Department of Laboratory Medicine, Salisbury NHS Foundation Trust, Salisbury SP2 8BJ, UK.
  • Centre for Medical Education, Queen's University Belfast, Belfast BT7 1NN, UK.
  • Department of Clinical Biochemistry, Belfast Health and Social Care Trust, Belfast BT13 1FD, UK.

ORCID-Profile: Anthony S Wierzbicki, Michael Mansfield

Zitieren

APA

Bashir, B., Ho, J. H., Downie, P., Hamilton, P., Ferns, G., Datta, D., Cegla, J., Wierzbicki, A. S., Dawson, C., Jenkinson, F., Delaney, H., Mansfield, M., Teoh, Y., Miedzybrodzka, Z., Haso, H., Durrington, P. N., & Soran, H. (2023). Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome—Causes, Clinical Presentation, and Therapeutic Options. Metabolites, 13(5), 621. https://doi.org/10.3390/metabo13050621

Vancouver

Bashir B, Ho JH, Downie P, Hamilton P, Ferns G, Datta D, et al. Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome—Causes, Clinical Presentation, and Therapeutic Options. Metabolites. 2023;13(5):621. doi:10.3390/metabo13050621

BibTeX
@article{Bashir2023,
  author = {Bashir, Bilal and Ho, Jan H and Downie, Paul and Hamilton, Paul and Ferns, Gordon and Datta, Dev and Cegla, Jaimini and Wierzbicki, Anthony S and Dawson, Charlotte and Jenkinson, Fiona and Delaney, Hannah and Mansfield, Michael and Teoh, Yee and Miedzybrodzka, Zosia and Haso, Haya and Durrington, Paul N and Soran, Handrean},
  title = {Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome—Causes, Clinical Presentation, and Therapeutic Options},
  journal = {Metabolites},
  year = {2023},
  volume = {13},
  number = {5},
  pages = {621},
  doi = {10.3390/metabo13050621}
}
Kostenlos starten →